Co-Diagnostics, Inc. (CODX) › Total LiabilitiesCo-Diagnostics, Inc. (CODX) — Total LiabilitiesAnnual figures by period end, from SEC filings.2016-12-31: $4.29M2017-12-31: $811.8K2018-12-31: $2.61M2019-12-31: $478.1K2020-12-31: $4.54M2021-12-31: $25.56M2022-12-31: $8.57M2023-12-31: $9.31M2024-12-31: $9.69M2025-12-31: $4.11M$4.11M2016-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$4.11M-57.5%2026-03-31Balance as of period end2024-12-31$9.69M+4.1%2026-03-31Balance as of period end2023-12-31$9.31M+8.6%2025-03-27Balance as of period end2022-12-31$8.57M-66.5%2024-03-14Balance as of period end2021-12-31$25.56M+462.9%2023-03-16Balance as of period end2020-12-31$4.54M+849.8%2022-03-24Balance as of period end2019-12-31$478.1K-81.7%2021-03-25Balance as of period end2018-12-31$2.61M+221.8%2020-03-30Balance as of period end2017-12-31$811.8K-81.1%2019-04-01Balance as of period end2016-12-31$4.29M—2018-03-28Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)